AzTrials
AzTrials

Anxiety DepressionNCT07274865

Prevalence of Psychiatric Problems Among Patients and Healthcare Providers in a Cardiology Department: A Cross-Sectional Study

An observational study of Anxiety Depression and Burnout, run by Assiut University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational cross-sectional study is to determine the prevalence of psychiatric problems (depression, anxiety, stress, and burnout) among patients with cardiovascular diseases and healthcare providers working in the Department of Cardiovascular Medicine at Assiut University Heart Hospital. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anxiety Depression, Burnout, Sleep
What is being tested?
Psychological Assessment using Validated Questionnaires
How many people
380 participants
Where
1 siteEgypt
Study dates
Jan 2026to Mar 2028
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adults with cardiovascular diseases admitted to or attending the outpatient clinics of the Cardiology Department at Assiut University Heart Hospital, and healthcare providers (physicians, residents, nurses, and technicians) currently working in the same department.

Who may be able to join

  • Patients
  • Age ≥ 18 years. Diagnosed with a cardiovascular disease (e.g., ischemic heart disease, heart failure, valvular disease).
  • Able to understand and complete self-administered questionnaires or participate in structured interviews.
  • Provided informed written consent.
  • Healthcare Providers
  • Physicians, residents, nurses, or allied staff working in the Department of Cardiovascular Medicine for ≥6 months.
  • Provided informed written consent.

Who cannot join

  • Severe cognitive impairment or communication difficulties that prevent questionnaire completion.
  • Refusal to participate.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hossam Loly Abdullah, bachelor's contact

00201279533575

hossam.17289754@med.aun.edu.eg

Egypt1 site

  • Assiut university hospital

    Asyut, Asyut Governorate, 71515

    Assiut university hospital, 0020882080150, vp_grad@aun.edu.eg

Other trials in Egypt

About this study

Official title: Prevalence of Psychiatric Problems Among Patients and Healthcare Providers in the Department of Cardiovascular Medicine

The goal of this observational cross-sectional study is to determine the prevalence of psychiatric problems (depression, anxiety, stress, and burnout) among patients with cardiovascular diseases and healthcare providers working in the Department of Cardiovascular Medicine at Assiut University Heart Hospital.

The main questions it aims to answer are:

  • What is the prevalence of depression, anxiety, and stress among cardiovascular patients?
  • What is the prevalence of burnout, depression, and anxiety among healthcare providers in the same department?

The study will also explore potential sociodemographic, occupational, and clinical factors associated with these psychological outcomes.

Read the detailed description

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Psychological comorbidities-such as depression, anxiety, post-traumatic stress disorder, and cognitive impairment-are highly prevalent among patients with CVD and are known to adversely affect treatment adherence, quality of life, and overall outcomes.

Similarly, healthcare professionals working in cardiovascular medicine are exposed to continuous psychological stress due to long working hours, critical decision-making, and frequent exposure to life-threatening situations. These stressors contribute to burnout, depression, anxiety, and reduced job satisfaction, all of which may negatively influence patient safety and workforce stability.

Despite the recognized importance of mental health in cardiology, limited data exist from low- and middle-income countries-particularly from Egypt-regarding the concurrent assessment of mental health among both patients and healthcare providers within the same clinical setting.

Therefore, this study aims to estimate the prevalence and correlates of psychiatric symptoms among cardiovascular patients and healthcare providers in a tertiary care center. The results are expected to guide the development of psychosocial support programs and promote mental health awareness in hospital cardiology departments.

Study Design:

Type: Cross-sectional, descriptive, hospital-based study

Setting: Assiut University Heart Hospital

Sample: ~380 cardiovascular patients (systematic random sampling) and all available healthcare providers (census approach)

Tools: Standardized and validated questionnaires including SCL-90R, PSS, PSQI, MBI, and COPE Inventory

Data Analysis: Descriptive and multivariate logistic regression analyses using SPSS v26

Being tested
Psychological Assessment using Validated Questionnaires
Keywords
psychiatric probldems in cardiologists, psychiatric problems in cardiovascular patients
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychological Assessment using Validated QuestionnairesOther

    Participants will complete validated mental health questionnaires, including SCL-90R, COPE Inventory, Eysenck Personality Questionnaire, Perceived Stress Scale (PSS), Pittsburgh Sleep Quality Index (PSQI). Healthcare providers will additionally complete the Maslach Burnout Inventory (MBI). No experimental treatment or behavioral intervention will be applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measuring the prevalence of depressive symptoms among cardiovascular patients assessed by SCL-90R

    The Symptom Checklist-90-Revised (SCL-90R) will be used to assess depression subscale scores among patients with cardiovascular diseases. A predefined cutoff score indicates the presence of depressive symptoms.

    Unit of measure: Percentage of participants with depressive symptoms (%)

    Measured: Within 12 months

  2. Measuring the prevalence of anxiety symptoms among cardiovascular patients assessed by SCL-90R

    Anxiety subscale of SCL-90R will be used to quantify anxiety symptoms in patients.

    Unit of measure : Percentage of participants with anxiety symptoms (%)

    Measured: Within 12 months

  3. Prevalence of burnout among healthcare providers assessed by Maslach Burnout Inventory (MBI)

    The Maslach Burnout Inventory (MBI) will be used to assess emotional exhaustion, depersonalization, and personal accomplishment among cardiology staff.

    Unit of measure : Percentage of participants meeting burnout criteria (%)

    Measured: Within 12 months

Secondary outcomes (2)

  1. Association between sociodemographic and clinical factors and psychiatric symptoms

    Multivariate logistic regression will be used to identify predictors (e.g., age, sex, job type, disease severity) associated with depression, anxiety, and burnout.

    Unit is Odds ratio (95% CI).

    Measured: within 12 months

  2. Mean Perceived Stress Scale (PSS) score among patients and providers

    Perceived Stress Scale will be used to measure stress levels; higher scores indicate greater perceived stress.

    Unit of measure : Mean PSS score (0-40)

    Measured: within 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study startJan 2026 (estimated)
  3. Primary completionNov 2027 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
380 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07274865
Sponsor's protocol ID
psychiatry in cardiology
Status last verified
Dec 2025
First submitted
25 Sep 2025
Last updated
10 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PubMed 11556941

  • Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, West CP, Sloan J, Oreskovich MR. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012 Oct 8;172(18):1377-85. doi: 10.1001/archinternmed.2012.3199.

    PubMed 22911330

  • Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.

    PubMed 16717171

  • Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014 Mar 25;129(12):1350-69. doi: 10.1161/CIR.0000000000000019. Epub 2014 Feb 24.

    PubMed 24566200

Questions about this trial

What is this clinical trial studying?

An observational study of Anxiety Depression and Burnout, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hossam Loly Abdullah, bachelor's (00201279533575, hossam.17289754@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measuring the prevalence of depressive symptoms among cardiovascular patients assessed by SCL-90R (time frame: Within 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07274865, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in